Skip to main content

Advertisement

Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease

Fig. 3

Effectiveness of TNF inhibitor in improvement of disease activity index for entero-Behcet’s disease. a DAIBD in the CS without TNF-i group (n = 22), TNF-i group (all: n = 49), TNF-i with CS group (n = 20), and TNF-i without CS group (n = 29). b Comparison of changes in DAIBD between the CS without TNF-i group (n = 22) and TNF-i group (all: n = 49), and between the TNF-i with CS group (n = 20) and TNF-i without CS group (n = 29) (by Wilcoxon signed-rank test). (last observation carried forward). Abbreviations: CS, corticosteroid; TNF-i, TNF inhibitors; DAIBD, disease activity index for intestinal Behcet’s disease

Back to article page